Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
In most cases, adults may qualify for GLP-1 weight loss medications with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as high blood pressure, type 2 diabetes, prediabetes, high cholesterol, sleep apnea, or cardiovascular disease
Thats the year that the last patent on semaglutide expires
The platform describes access to branded FDA-approved GLP-1 medications including Wegovy, Zepbound, Ozempic, Mounjaro, and others
Takeaway The vision is for real-world patients on each of these drugs to be followed over the next two to four years to see what happens to their cardiac risk scores, and how that relates to their body mass index or other comorbidities
US$ 20.41
US$ 26.64
US$ 24.94
US$ 28.85
US$ 29.58
US$ 22.67
